Company shares climbed by more than 20% on Phase 2 study results suggesting the therapy could provide sustained relief when ...
The partners said the shot produced “clinically meaningful” efficacy despite missing its main study objective, a finding they ...
Industry executives can share their views on the “national priority” program at a June meeting. Elsewhere, Sanofi licensed a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results